Cargando…
The role of c-kit and imatinib mesylate in uveal melanoma
BACKGROUND: Uveal melanoma (UM) is the most common primary intraocular tumor in adults, leading to metastasis in 40% of the cases and ultimately to death in 10 years, despite local and/or systemic treatment. The c-kit protein (CD117) is a membrane-bound tyrosine kinase receptor and its overexpressio...
Autores principales: | Pereira, Patricia Rusa, Odashiro, Alexandre Nakao, Marshall, Jean Claude, Correa, Zelia Maria, Belfort, Rubens, Burnier, Miguel N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1282581/ https://www.ncbi.nlm.nih.gov/pubmed/16236162 http://dx.doi.org/10.1186/1477-3163-4-19 |
Ejemplares similares
-
Current and emerging treatment options for uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2013) -
Imatinib Mesylate Alters the Expression of Genes Related to Disease Progression in an Animal Model of Uveal Melanoma
por: Fernandes, Bruno F., et al.
Publicado: (2011) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006) -
Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma
por: Fernandes, Bruno F, et al.
Publicado: (2007) -
Malignancy in the blind painful eye – report of two cases and literature review
por: Pereira, Patrícia Rusa, et al.
Publicado: (2006)